Burkholderia stabilis infections associated with contamination of non-sterile alcohol-free skin cleansing wipes, United Kingdom, 2018 to 2026 [0.03%]
2018年至2026年英国无酒精免洗手消毒湿巾污染引起的伯克霍尔德菌稳定亚种感染事件
Aideen Carroll,Rebecca Stretch,Dan Blackman et al.
Aideen Carroll et al.
A Burkholderia stabilis (ST480) outbreak associated with skin cleansing wipes has comprised 59 confirmed cases in the United Kingdom 2018-2026. Cases included patients with co-morbidities and clinically relevant infections. There was one as...
Two-season effectiveness of a single nirsevimab dose against RSV hospitalisation in healthy term-born infants: a population-based case-control study, Spain, October 2023 to March 2025 [0.03%]
一项基于人口的病例对照研究：单次 nirsevimab 剂量对健康足月婴儿呼吸道合胞病毒住院的有效性，西班牙，2023年10月至2025年3月
Olivier Núñez,Juan Juaneda,Montserrat Martinez-Marcos et al.
Olivier Núñez et al.
BACKGROUNDIn autumn 2023, Spain recommended nirsevimab to all infants born after 1 April 2023, as catch-up or at-birth immunisation.AIMWe estimated effectiveness of a single nirsevimab dose against respiratory syncytial virus (RSV) hospital...
Cross-sectional seroprevalence study of measles antibodies among children to identify gaps in population immunity, Ireland, 2024 [0.03%]
2024年爱尔兰儿童麻疹抗体横断面血清流行率研究以识别人群免疫缺口
Melissa Brady,Lieke Brouwer,Katie O&#x; Brien et al.
Melissa Brady et al.
BACKGROUNDGlobal resurgence of measles highlights the need for countries to identify and address immunity gaps. This is challenging given antibody waning and, in Ireland, the absence of robust national vaccine coverage data, population chan...
Nationwide outbreak of Shiga toxin-producing Escherichia coli infections associated with frozen pizzas, France, 2022 [0.03%]
法国关联冷冻比萨的产志贺毒素型大肠杆菌感染全国暴发疫情，2022年
Catarina Krug,Nathalie Jourdan-Da Silva,Mathieu Tourdjman et al.
Catarina Krug et al.
In February 2022, we observed an increase in the number of paediatric patients with haemolytic uraemic syndrome (HUS) associated with Shiga toxin-producing Escherichia coli (STEC) in France. We interviewed cases or caretakers about food exp...
Two cases of possible transmitted HIV drug resistance to all currently available integrase inhibitors, the Netherlands, 2025 [0.03%]
两个可能存在对目前所有可用整合酶抑制剂产生抗药性的艾滋病病毒(VIRAL LOAD检测)传染病例，荷兰，2025年
Jeroen van Kampen,Jolanda Voermans,Widia Soochit et al.
Jeroen van Kampen et al.
Transmitted integrase inhibitor resistance in newly diagnosed HIV remains rare. We report two cases with baseline resistance to all currently available integrase inhibitors in the Netherlands in 2025. Clinical history and laboratory finding...
Eurosurveillance editorial team
Eurosurveillance editorial team
Individual and seasonal determinants of death among influenza patients in intensive care units: a retrospective cohort study, Portugal, 2012 to 2024 [0.03%]
重症监护病房流感患者的死亡个体和季节决定因素：2012年至2024年葡萄牙的回顾性队列研究
Sebastian von Schreeb,Ana Firme,Mariana Ferreira et al.
Sebastian von Schreeb et al.
BACKGROUNDPortugal is establishing a surveillance system for severe acute respiratory infection (SARI). Data from its existing influenza surveillance system in intensive care units (ICU), operating since 2012, has not yet been analysed.AIMW...
Feasibility of conducting brand-specific influenza vaccine effectiveness studies in three Nordic countries, Denmark, Finland, Sweden [0.03%]
在北欧三国开展针对流感疫苗品牌特异性的效果研究的可行性：丹麦、芬兰和瑞典
Kristyna Faksova,Emilia Myrup Thiesson,Nicklas Pihlström et al.
Kristyna Faksova et al.
Annual reformulation and approval of seasonal influenza vaccines necessitate yearly evaluation of their effectiveness. Regulatory agencies, including the European Medicines Agency (EMA), rely on timely, real-world evidence to inform product...
Retraction note: Moderate protection from vaccination against influenza A(H3N2) subclade K in Beijing, China, September to December 2025 (Euro Surveill. 2026;31(2)) [0.03%]
撤稿说明：疫苗对北京流感A(H3N2)亚谱系K的中度保护效果（2025年9月至12月）(Euro Surveill. 2026;31(2))
Eurosurveillance editorial team
Eurosurveillance editorial team
Influenza vaccine effectiveness from nine studies during drifted A(H3N2) subclade K predominance, Europe, September 2025 to January 2026 [0.03%]
2025年9月至2026年1月欧亚型(H3N2)K次谱系流行期间的九项研究中的流感疫苗效力
Heloise Lucaccioni,Diogo Fp Marques,Freja Kirsebom et al.
Heloise Lucaccioni et al.
The European 2025/26 influenza season is dominated by the influenza A(H3N2) virus, with most sequenced viruses belonging to subclade K, genetically drifted from the vaccine virus, raising concerns around vaccine effectiveness (VE). Despite ...